Suppr超能文献

GABAB 受体正变构调节剂 CGP7930 在未成年大鼠中的抗惊厥作用。

Anticonvulsant action of GABAB receptor positive modulator CGP7930 in immature rats.

机构信息

Department of Developmental Epileptology, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.

出版信息

Epilepsy Res. 2012 Jun;100(1-2):49-54. doi: 10.1016/j.eplepsyres.2012.01.007. Epub 2012 Feb 15.

Abstract

GABA(B) receptors mediate inhibition at early stages of development but mixed anti-and proconvulsant action of their agonists affecting all receptors was found in immature rats. Positive allosteric modulators of GABA(B) receptors potentiate only already active GABA(B) receptors and therefore more specific action is expected. Possible anticonvulsant action of CGP7930 was studied in a model of pentetrazol-induced seizures previously used for studies with agonists baclofen and SKF97541. Pentetrazol (100mg/kg) was administered subcutaneously in male rats 7, 12, 18, 25 and 90 days old pretreated with CGP7930 in doses 1-40 mg/kg i.p. High doses of CGP7930 suppressed generalized tonic-clonic seizures in all five age groups. Animals 18 and less days old exhibited a specific suppression of the tonic phase after lower doses of CGP7930. Twelve-day-old rats were the most sensitive to anticonvulsant effect of CGP7930 (even the 2-mg/kg dose suppressed the tonic phase whereas 20-mg/kg dose was active in other age groups). Minimal clonic seizures (mS) were moderately potentiated by low doses of CGP7930 in 18-day-old but suppressed by the highest dose in 25-day-old rats. The 60-mg/kg dose of PTZ induced only mS in 4 out of 9 25-day-old rats; the 40-mg/kg dose of CGP7930 combined with this lower dose of PTZ resulted in the only proconvulsant effect--generalized tonic-clonic seizures appeared in two rats. Results from 12-day-old rats suggest a possibility to find an age-specific anticonvulsant among positive allosteric modulators of GABA(B) receptors.

摘要

GABA(B) 受体在发育早期介导抑制作用,但在未成熟大鼠中发现其激动剂具有混合的抗惊厥和促惊厥作用,影响所有受体。GABA(B) 受体的正变构调节剂仅增强已经活跃的 GABA(B) 受体,因此预计会有更特异的作用。CGP7930 的可能抗惊厥作用在先前用于研究激动剂巴氯芬和 SKF97541 的戊四唑诱导惊厥模型中进行了研究。戊四唑(100mg/kg)皮下给予 7、12、18、25 和 90 天大的雄性大鼠,预先用 CGP7930 腹腔内给药 1-40mg/kg。高剂量的 CGP7930 抑制了所有五个年龄组的全身性强直-阵挛性发作。较低剂量的 CGP7930 后,18 天及以下的动物表现出对强直相的特异性抑制。12 天大的大鼠对 CGP7930 的抗惊厥作用最为敏感(甚至 2mg/kg 剂量抑制了强直相,而 20mg/kg 剂量在其他年龄组中有效)。在 18 天大的大鼠中,CGP7930 的低剂量适度增强了轻度阵挛发作(mS),但在 25 天大的大鼠中,高剂量抑制了 mS。在 9 只 25 天大的大鼠中,只有 4 只接受了 60mg/kg 的 PTZ 剂量仅引起 mS;与较低剂量的 PTZ 联合使用 40mg/kg 的 CGP7930 导致了唯一的促惊厥作用——在两只大鼠中出现全身性强直-阵挛性发作。来自 12 天大的大鼠的结果表明,在 GABA(B) 受体的正变构调节剂中可能找到一种年龄特异性的抗惊厥药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验